Evoke Pharma Inc expected to post a loss of 60  cents a share - Earnings Preview

Evoke Pharma

09/08/2022 03:03

* Evoke Pharma Inc  EVOK.OQ   EVOK.O  is expected to show a
rise
in quarterly revenue when it reports  results on August 10. 
    * The Solana Beach California-based  company is expected to
report
 a 145.1% increase in revenue to $580 thousand from $236.64
thousand a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Evoke Pharma Inc is
for a
loss of 60 cents per share. For the same quarter last year, the
company reported a loss of 84 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Evoke
Pharma Inc
is $78​, above​ its last closing price of $3.39. ​​​

This summary was machine generated August 9 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated